ENZC Stock Price and Chart — OTC:ENZC — TradingView

Overview

Financials News Ideas Discussions Technicals Seasonals

ENZC chart

Key stats

About Enzolytics Inc.

Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments. The company’s all-human monoclonal antibodies target and neutralize human immunodeficiency virus and are being employed to produce anti-SARS-CoV-2 monoclonal antibodies for treating COVID-19. Its proprietary therapeutic is also being tested against Hepatitis A, B and C, Rheumatoid Arthritis, certain forms of cancer, rabies, influenza A and B, tetanus, and diphtheria. The company was founded on July 28, 2004 and is headquartered in Allen, TX.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

See all ideas

Technicals

Summarizing what the indicators are suggesting.

Oscillators

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Oscillators

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Summary

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Summary

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Summary

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Moving Averages

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Moving Averages

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

The current price of ENZC is 0.0010 USD — it has decreased by −13.64% in the past 24 hours. Watch Enzolytics Inc. stock price performance more closely on the chart.

Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Enzolytics Inc. stocks are traded under the ticker ENZC.

ENZC stock has fallen by −13.64% compared to the previous week, the month change is a 5.56% rise, over the last year Enzolytics Inc. has showed a −91.36% decrease.

ENZC reached its all-time high on Dec 29, 2008 with the price of 30,000.0000 USD, and its all-time low was 0.0001 USD and was reached on Mar 19, 2020. View more price dynamics on ENZC chart.
See other stocks reaching their highest and lowest prices.

ENZC stock is 33.33% volatile and has beta coefficient of 0.57. Track Enzolytics Inc. stock price on the chart and check out the list of the most volatile stocks — is Enzolytics Inc. there?

Today Enzolytics Inc. has the market capitalization of ‪3.74 M‬, it has decreased by −8.33% over the last week.

Yes, you can track Enzolytics Inc. financials in yearly and quarterly reports right on TradingView.

ENZC net income for the last quarter is ‪−31.44 K‬ USD, while the quarter before that showed ‪−1.82 K‬ USD of net income which accounts for ‪−1.63 K‬% change. Track more Enzolytics Inc. financial stats to get the full picture.

No, ENZC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, ENZC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enzolytics Inc. stock right from TradingView charts — choose your broker and connect to your account.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Enzolytics Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Enzolytics Inc. stock shows the sell signal. See more of Enzolytics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.